OSI Pharmaceuticals, Inc. (OSIP)
$33.32
0.18 (+0.54%)
| CAPS Rating |
|
|---|---|
| Open | $32.90 |
| Previous Close | $33.14 |
| Daily Range | $32.51 - $33.53 |
| 52-Week Range | $27.01 - $43.00 |
| Market Cap | $1.93B |
| P/E Ratio | 4.50 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 442,033 |
| Average Daily Volume | 989,000 |
OSIP
VS S&P 500 (SPY)
How do you think OSIP will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
OSIP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
OSIP News and Commentary
- This Top Stock Is a Winner – The Motley Fool
- Seeking Alpha on OSI Pharmaceuticals, Inc. – Ockham-RazorWire
- UPDATE 1-OSI Pharma posts higher Tarceva global sales in Q3 – Reuters
- 4-Star Stocks on the Upswing – The Motley Fool
- Lilly Shows Us How It's Done – The Motley Fool
- Tomorrow's Monster Stocks – The Motley Fool
- Make Money, Fight Disease: The ASCO Preview – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Growth in All the Wrong Places – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Which One of These Is Not Like the Other? – The Motley Fool
- The Comeback of the Century? – The Motley Fool
- Double Trouble for AstraZeneca – The Motley Fool
- 5-Star Stocks Poised to Pop: Genzyme – The Motley Fool
- Regeneron's Results Clearing Up – The Motley Fool
- Exelixis Gets Ready to Partner Up – The Motley Fool
- Onyx in the Black -- for Now – The Motley Fool
- A Big Upgrade for Onyx Pharmaceuticals – The Motley Fool
- A Big Move From ViroPharma – The Motley Fool
- A Big Upgrade for ImClone – The Motley Fool
RSS Headlines
Fool UK
